Disrupting the APC-Asef Interaction Suppresses Cancer Cell Migration [Drug Design]
Structure-based design yields peptidomimetic APC–ARM pocket inhibitors that block Asef binding.
Source: Cancer Discovery - Category: Cancer & Oncology Tags: Drug Design Source Type: research
More News: Cancer | Cancer & Oncology